246137-74-6Relevant articles and documents
Discovery of novel phosphatidylcholine-specific phospholipase C drug-like inhibitors as potential anticancer agents
Barker, David,Brar, Harpreet Kaur,Eurtivong, Chatchakorn,Leung, Euphemia,Leung, Ivanhoe K. H.,Paulin, Emily K.,Pilkington, Lisa I.,Rees, Shaun,Reynisson, Jóhannes,Sharma, Nabangshu,White, Reuben M.,Xu, Chris Sun,van Rensburg, Michelle
supporting information, (2019/12/24)
Phosphatidylcholine–specific phospholipase C (PC-PLC) is a promising target for new anticancer treatment. Herein, we report our work in the discovery of novel drug-like PC-PLC inhibitors. Virtual screening led to the identification of promising hits from
Synthesis and biological evaluation of new tetrahydro-β-carbolines as inhibitors of the mitotic kinesin Eg5
Sunder-Plassmann, Nils,Sarli, Vasiliki,Gartner, Michael,Utz, Mathias,Seiler, Jeanette,Huemmer, Stefan,Mayer, Thomas U.,Surrey, Thomas,Giannis, Athanassios
, p. 6094 - 6111 (2007/10/03)
The mitotic kinesin Eg5 (or KSP) is a crucial player in the development and function of the mitotic spindle. Inhibition of this protein leads to cell cycle arrest and apoptosis without interfering with other microtubule-dependent processes. Therefore, it
